Effect of molecular charges on renal uptake of 111In-DTPA-conjugated peptides

Hiromichi Akizawa, Yasushi Arano, Masaki Mifune, Akimasa Iwado, Yutaka Saito, Takahiro Mukai, Tomoya Uehara, Masahiro Ono, Yasushi Fujioka, Kazuma Ogawa, Yoshiaki Kiso, Hideo Saji

Research output: Contribution to journalArticle

85 Citations (Scopus)

Abstract

The effect of molecular charges on renal accumulation of 111In-DTPA-labeled low molecular weight (LMW) peptides was investigated using 111In-DTPA-octreotide derivatives as models to design radiolabeled peptides that are taken up less by renal cells. The N-terminal D-phenylalanine (Phe) of 111In-DTPA-D-Phe1-octreotide was replaced with L-aspartic acid (Asp), L-lysine (Lys), L-methionine (Met) or L-Phe. Cellulose acetate electrophoresis indicated that both 111In-DTPA-L-Phe1-octreotide and 111In-DTPA-L-Met1-octreotide showed similar net charges, whereas 111In-DTPA-L-αLys1-octreotide and 111In-DTPA-L-Asp1-octreotide had more positive and negative charges, respectively, at pH values similar to those in blood and glomerular filtrate. When injected into mice, significant differences were observed in the renal radioactivity levels. 111In-DTPA-L-αLys1-octreotide showed the highest radioactivity levels from 10 min to 6 h postinjection, whereas the lowest radioactivity levels were observed with 111In-DTPA-L-Asp1-octreotide at all the postinjection intervals. These findings indicated that the replacement of only one amino acid in 111In-DTPA-D-Phe1-octreotide significantly altered net molecular charges of the resulting peptides and that the net charges of the 111In-DTPA-octreotide derivatives significantly affected their renal uptake. Thus, an increase of negative charges in peptide molecules may constitute a strategy for designing 111In-DTPA-conjugated LMW peptides with low renal radioactivity levels.

Original languageEnglish
Pages (from-to)761-768
Number of pages8
JournalNuclear Medicine and Biology
Volume28
Issue number7
DOIs
Publication statusPublished - 2001

Fingerprint

Pentetic Acid
Kidney
Peptides
Octreotide
Radioactivity
Molecular Weight
Cellulose Acetate Electrophoresis
Phenylalanine
Aspartic Acid
Methionine
Lysine

Keywords

  • In-DTPA-peptide
  • Molecular charge
  • Octreotide
  • Re-absorption
  • Renal radioactivity localization

ASJC Scopus subject areas

  • Cancer Research
  • Molecular Medicine
  • Radiology Nuclear Medicine and imaging

Cite this

Effect of molecular charges on renal uptake of 111In-DTPA-conjugated peptides. / Akizawa, Hiromichi; Arano, Yasushi; Mifune, Masaki; Iwado, Akimasa; Saito, Yutaka; Mukai, Takahiro; Uehara, Tomoya; Ono, Masahiro; Fujioka, Yasushi; Ogawa, Kazuma; Kiso, Yoshiaki; Saji, Hideo.

In: Nuclear Medicine and Biology, Vol. 28, No. 7, 2001, p. 761-768.

Research output: Contribution to journalArticle

Akizawa, H, Arano, Y, Mifune, M, Iwado, A, Saito, Y, Mukai, T, Uehara, T, Ono, M, Fujioka, Y, Ogawa, K, Kiso, Y & Saji, H 2001, 'Effect of molecular charges on renal uptake of 111In-DTPA-conjugated peptides', Nuclear Medicine and Biology, vol. 28, no. 7, pp. 761-768. https://doi.org/10.1016/S0969-8051(01)00241-4
Akizawa, Hiromichi ; Arano, Yasushi ; Mifune, Masaki ; Iwado, Akimasa ; Saito, Yutaka ; Mukai, Takahiro ; Uehara, Tomoya ; Ono, Masahiro ; Fujioka, Yasushi ; Ogawa, Kazuma ; Kiso, Yoshiaki ; Saji, Hideo. / Effect of molecular charges on renal uptake of 111In-DTPA-conjugated peptides. In: Nuclear Medicine and Biology. 2001 ; Vol. 28, No. 7. pp. 761-768.
@article{515771df7b784d82b289cabf0f04baed,
title = "Effect of molecular charges on renal uptake of 111In-DTPA-conjugated peptides",
abstract = "The effect of molecular charges on renal accumulation of 111In-DTPA-labeled low molecular weight (LMW) peptides was investigated using 111In-DTPA-octreotide derivatives as models to design radiolabeled peptides that are taken up less by renal cells. The N-terminal D-phenylalanine (Phe) of 111In-DTPA-D-Phe1-octreotide was replaced with L-aspartic acid (Asp), L-lysine (Lys), L-methionine (Met) or L-Phe. Cellulose acetate electrophoresis indicated that both 111In-DTPA-L-Phe1-octreotide and 111In-DTPA-L-Met1-octreotide showed similar net charges, whereas 111In-DTPA-L-αLys1-octreotide and 111In-DTPA-L-Asp1-octreotide had more positive and negative charges, respectively, at pH values similar to those in blood and glomerular filtrate. When injected into mice, significant differences were observed in the renal radioactivity levels. 111In-DTPA-L-αLys1-octreotide showed the highest radioactivity levels from 10 min to 6 h postinjection, whereas the lowest radioactivity levels were observed with 111In-DTPA-L-Asp1-octreotide at all the postinjection intervals. These findings indicated that the replacement of only one amino acid in 111In-DTPA-D-Phe1-octreotide significantly altered net molecular charges of the resulting peptides and that the net charges of the 111In-DTPA-octreotide derivatives significantly affected their renal uptake. Thus, an increase of negative charges in peptide molecules may constitute a strategy for designing 111In-DTPA-conjugated LMW peptides with low renal radioactivity levels.",
keywords = "In-DTPA-peptide, Molecular charge, Octreotide, Re-absorption, Renal radioactivity localization",
author = "Hiromichi Akizawa and Yasushi Arano and Masaki Mifune and Akimasa Iwado and Yutaka Saito and Takahiro Mukai and Tomoya Uehara and Masahiro Ono and Yasushi Fujioka and Kazuma Ogawa and Yoshiaki Kiso and Hideo Saji",
year = "2001",
doi = "10.1016/S0969-8051(01)00241-4",
language = "English",
volume = "28",
pages = "761--768",
journal = "Nuclear Medicine and Biology",
issn = "0969-8051",
publisher = "Elsevier Inc.",
number = "7",

}

TY - JOUR

T1 - Effect of molecular charges on renal uptake of 111In-DTPA-conjugated peptides

AU - Akizawa, Hiromichi

AU - Arano, Yasushi

AU - Mifune, Masaki

AU - Iwado, Akimasa

AU - Saito, Yutaka

AU - Mukai, Takahiro

AU - Uehara, Tomoya

AU - Ono, Masahiro

AU - Fujioka, Yasushi

AU - Ogawa, Kazuma

AU - Kiso, Yoshiaki

AU - Saji, Hideo

PY - 2001

Y1 - 2001

N2 - The effect of molecular charges on renal accumulation of 111In-DTPA-labeled low molecular weight (LMW) peptides was investigated using 111In-DTPA-octreotide derivatives as models to design radiolabeled peptides that are taken up less by renal cells. The N-terminal D-phenylalanine (Phe) of 111In-DTPA-D-Phe1-octreotide was replaced with L-aspartic acid (Asp), L-lysine (Lys), L-methionine (Met) or L-Phe. Cellulose acetate electrophoresis indicated that both 111In-DTPA-L-Phe1-octreotide and 111In-DTPA-L-Met1-octreotide showed similar net charges, whereas 111In-DTPA-L-αLys1-octreotide and 111In-DTPA-L-Asp1-octreotide had more positive and negative charges, respectively, at pH values similar to those in blood and glomerular filtrate. When injected into mice, significant differences were observed in the renal radioactivity levels. 111In-DTPA-L-αLys1-octreotide showed the highest radioactivity levels from 10 min to 6 h postinjection, whereas the lowest radioactivity levels were observed with 111In-DTPA-L-Asp1-octreotide at all the postinjection intervals. These findings indicated that the replacement of only one amino acid in 111In-DTPA-D-Phe1-octreotide significantly altered net molecular charges of the resulting peptides and that the net charges of the 111In-DTPA-octreotide derivatives significantly affected their renal uptake. Thus, an increase of negative charges in peptide molecules may constitute a strategy for designing 111In-DTPA-conjugated LMW peptides with low renal radioactivity levels.

AB - The effect of molecular charges on renal accumulation of 111In-DTPA-labeled low molecular weight (LMW) peptides was investigated using 111In-DTPA-octreotide derivatives as models to design radiolabeled peptides that are taken up less by renal cells. The N-terminal D-phenylalanine (Phe) of 111In-DTPA-D-Phe1-octreotide was replaced with L-aspartic acid (Asp), L-lysine (Lys), L-methionine (Met) or L-Phe. Cellulose acetate electrophoresis indicated that both 111In-DTPA-L-Phe1-octreotide and 111In-DTPA-L-Met1-octreotide showed similar net charges, whereas 111In-DTPA-L-αLys1-octreotide and 111In-DTPA-L-Asp1-octreotide had more positive and negative charges, respectively, at pH values similar to those in blood and glomerular filtrate. When injected into mice, significant differences were observed in the renal radioactivity levels. 111In-DTPA-L-αLys1-octreotide showed the highest radioactivity levels from 10 min to 6 h postinjection, whereas the lowest radioactivity levels were observed with 111In-DTPA-L-Asp1-octreotide at all the postinjection intervals. These findings indicated that the replacement of only one amino acid in 111In-DTPA-D-Phe1-octreotide significantly altered net molecular charges of the resulting peptides and that the net charges of the 111In-DTPA-octreotide derivatives significantly affected their renal uptake. Thus, an increase of negative charges in peptide molecules may constitute a strategy for designing 111In-DTPA-conjugated LMW peptides with low renal radioactivity levels.

KW - In-DTPA-peptide

KW - Molecular charge

KW - Octreotide

KW - Re-absorption

KW - Renal radioactivity localization

UR - http://www.scopus.com/inward/record.url?scp=0034802793&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034802793&partnerID=8YFLogxK

U2 - 10.1016/S0969-8051(01)00241-4

DO - 10.1016/S0969-8051(01)00241-4

M3 - Article

VL - 28

SP - 761

EP - 768

JO - Nuclear Medicine and Biology

JF - Nuclear Medicine and Biology

SN - 0969-8051

IS - 7

ER -